Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



MAST ERLE T Create: Alert

All | News | Filings
Date FiledTypeDescription
03/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/21/2022 4 MAST ERLE T (Director) has filed a Form 4 on ZOGENIX, INC.
Txns: Sold 15,000 shares @ $26.0864, valued at $391.3k
Exercised 6,250 options to buy @ $15.04, valued at $94k
Exercised 4,375 options to buy @ $14.88, valued at $65.1k
Exercised 4,375 options to buy @ $12, valued at $52.5k
05/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/28/2019 4 MAST ERLE T (Director) has filed a Form 4 on ZOGENIX, INC.
Txns: Granted 13,000 options to buy @ $39.02, valued at $507.3k
11/26/2018 4 MAST ERLE T (Director) has filed a Form 4 on ZOGENIX, INC.
Txns: Sold 1,468 shares @ $42.0792, valued at $61.8k
10/04/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2018 4 MAST ERLE T (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns: Granted 10,000 options to buy @ $15.08, valued at $150.8k
05/24/2018 4 MAST ERLE T (Director) has filed a Form 4 on ZOGENIX, INC.
Txns: Granted 15,000 options to buy @ $41.68, valued at $625.2k
08/01/2017 4 MAST ERLE T (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns: Bought 6,700 shares @ $15, valued at $100.5k
07/26/2017 3 MAST ERLE T (Director) has filed a Form 3 on Sienna Biopharmaceuticals, Inc.
05/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
07/15/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/03/2015 4 MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns: Sold 89 shares @ $98.82, valued at $8.8k
Sold 111 shares @ $100.8027, valued at $11.2k
Sold 100 shares @ $102.67, valued at $10.3k
Sold 500 shares @ $104.284, valued at $52.1k
Sold 400 shares @ $105.095, valued at $42k
Sold 1,000 shares @ $106.3302, valued at $106.3k
Sold 700 shares @ $107.2886, valued at $75.1k
Sold 100 shares @ $108.16, valued at $10.8k
10/02/2015 4 MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns: Sold 900 shares @ $89.4, valued at $80.5k
Sold 1,580 shares @ $90.28, valued at $142.6k
Sold 420 shares @ $91.3, valued at $38.3k
Sold 100 shares @ $92.09, valued at $9.2k
09/03/2015 4 MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns: Sold 200 shares @ $76.39, valued at $15.3k
Sold 400 shares @ $78.2325, valued at $31.3k
Sold 1,000 shares @ $79.394, valued at $79.4k
Sold 1,300 shares @ $80.3431, valued at $104.4k
Sold 100 shares @ $81.07, valued at $8.1k
08/27/2015 4 MAST ERLE T (Director) has filed a Form 4 on Receptos, Inc.
Txns: Unknown transaction of 300 shares @ $0
Disposed/sold 7,400 shares @ $0
Disposed/sold 18,800 options to buy @ $18.77, valued at $352.9k
Disposed/sold 9,400 options to buy @ $27.44, valued at $257.9k
08/05/2015 4 MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns: Sold 1,190 shares @ $85.23, valued at $101.4k
Sold 1,310 shares @ $86.33, valued at $113.1k
Sold 500 shares @ $86.81, valued at $43.4k
07/02/2015 4 MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns: Sold 2,000 shares @ $85.19, valued at $170.4k
Sold 900 shares @ $86.56, valued at $77.9k
Sold 100 shares @ $88.01, valued at $8.8k
06/19/2015 4 MAST ERLE T (Director) has filed a Form 4 on ZOGENIX, INC.
Txns: Granted 72,000 options to buy @ $1.6, valued at $115.2k
06/03/2015 4 MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns: Sold 200 shares @ $86.04, valued at $17.2k
Sold 900 shares @ $87.635, valued at $78.9k
Sold 1,000 shares @ $88.903, valued at $88.9k
Sold 500 shares @ $89.988, valued at $45k
Sold 400 shares @ $90.873, valued at $36.3k
06/01/2015 4 MAST ERLE T (Director) has filed a Form 4 on Receptos, Inc.
Txns: Granted 7,400 shares @ $0
05/05/2015 4 MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns: Sold 879 shares @ $81.001, valued at $71.2k
Sold 1,800 shares @ $81.982, valued at $147.6k
Sold 221 shares @ $82.46, valued at $18.2k
Sold 100 shares @ $83.55, valued at $8.4k
04/03/2015 4 MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns: Sold 1,260 shares @ $70.515, valued at $88.8k
Sold 1,540 shares @ $71.571, valued at $110.2k
Sold 100 shares @ $72.65, valued at $7.3k
Sold 100 shares @ $74.31, valued at $7.4k
03/17/2015 4 MAST ERLE T (Director) has filed a Form 4 on ZOGENIX, INC.
Txns: Granted 7,500 shares @ $1.31, valued at $9.8k
03/11/2015 4 MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns: Sold 8,400 shares @ $78.7781, valued at $661.7k
Sold 500 shares @ $79.555, valued at $39.8k
Sold 100 shares @ $80.4, valued at $8k
03/04/2015 4 MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns: Granted 35,000 options to buy @ $79.05, valued at $2.8M
06/05/2014 4 MAST ERLE T (Director) has filed a Form 4 on Receptos, Inc.
Txns: Granted 9,400 options to buy @ $27.44, valued at $257.9k
05/22/2014 4 MAST ERLE T (Director) has filed a Form 4 on ZOGENIX, INC.
Txns: Granted 50,000 options to buy @ $1.94, valued at $97k
03/18/2014 4 MAST ERLE T (Director) has filed a Form 4 on Receptos, Inc.
Txns: Bought 200 shares @ $50.225, valued at $10k
Bought 100 shares @ $51.552, valued at $5.2k
01/14/2014 4 MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns: Granted 70,000 options to buy @ $73.98, valued at $5.2M
12/12/2013 4 MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns: Sold 25,177 shares @ $53.8106, valued at $1.4M
Sold 700 shares @ $54.57, valued at $38.2k
Sold 24,023 shares @ $51.6393, valued at $1.2M
Sold 100 shares @ $52.38, valued at $5.2k
07/19/2013 4 MAST ERLE T (Director) has filed a Form 4 on Receptos, Inc.
Txns: Granted 18,800 options to buy @ $18.77, valued at $352.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy